Fuda Cancer Hospital
Oncology treatment in China typically costs from $19,000 to $51,300 for a full course of care. Final expenses depend on the cancer stage, the specific technology used, and the length of hospital stay. International patients often find 50-85% savings compared to prices in the US.
Typical Oncology Costs in China
Major oncology centers are located in Beijing, Shanghai, and Guangzhou. While facilities in tier-1 cities like Beijing often charge more than regional hospitals, they provide access to English-speaking staff. Consult with a specialist to get an accurate price for your specific diagnosis.
| China | Turkey | Austria | |
| Thyroid resection | from $8,200 | from $3,500 | from $10,000 |
| Stomach cancer surgery | from $18,500 | from $22,320 | from $30,000 |
| Removal of spinal cord tumor | from $19,500 | from $9,650 | from $50,000 |
| Removal of liver cancer | from $21,500 | from $10,800 | from $40,000 |
| Removal of colon cancer | from $17,500 | from $14,400 | from $20,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Oncology treatment upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Oncology treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Oncology treatment journey.
Zhang Yanjun, MD, is a Chief Physician and Master’s Supervisor with 30 years of experience in tumor imaging and radiation oncology. He treats both pediatric and adult patients. His focus includes primary and secondary tumors, neuro-oncology, and stereotactic radiotherapy.
He is proficient in radiotherapy for cancers of the lung, liver, nasopharynx, head and neck, esophagus, breast, rectum, cervix, and prostate, as well as lymphoma and central nervous system tumors.
He is a member of the Central Nervous System Tumor Radiotherapy Group of the Second Committee of the Radiation Oncology Physicians Branch of the Chinese Medical Doctor Association. He serves on the Executive Committee of the First Chinese Oncology Radiation Therapy Cooperation Group of the World Association of Chinese Oncology Physicians. He is also a member of the National Digestive Oncology Expert Committee of the Radiation Oncology Professional Committee of the Wu Jieping Medical Foundation. He was a visiting scholar twice at leading U.S. cancer radiotherapy centers. He has published 46 papers in core journals and international conferences.
Nearly 10,000 cryosurgeries performed – Prof. Niu Lizhi leads Fuda Cancer Hospital's minimally invasive oncology program.
Dr. Liuying leads the Oncology Ward at Jinshazhou Hospital, Guangzhou University of Chinese Medicine. Clinical focus includes hepatocellular carcinoma, cholangiocarcinoma, and lung and colorectal cancers. Dr. Liuying has special expertise in melanoma and melanoma liver metastasis. Interventional skills include MWA, RFA, cryoablation, and radioactive seed implantation for non-vascular, minimally invasive tumor ablation.
Research: participated in two Guangdong Provincial science and technology projects. Contributed to the 2014 Expert Consensus for Thermal Ablation of Primary and Metastatic Lung Tumors. Published in the Chinese Journal of Lung Cancer. Compiled Selected Cases of Microwave Ablation for Lung Tumors and Selected Cases of Microwave Ablation for Liver Tumors.
Appointments: Standing Committee Member, Youth Committee of Intra-Tumor Brachytherapy Medicine, China Medical Education Association. Standing Committee Member, Minimally Invasive Interventional Medicine Professional Committee, Guangdong Primary Medical Association.
Dr. LV Xiao Jun is the Executive Director of the Department of Medical Oncology. He is a national expert in psycho-oncology and has 30 years of clinical experience. He previously served at the First Affiliated Hospital of Xiamen University. He is a recognized expert in cancer treatment and lung cancer care in Fujian Province.
Clinical focus: comprehensive care for solid tumors, including lung, breast, and gastrointestinal cancers; palliative care in oncology; and screening and treatment for psychological distress.
Appointments: Standing Committee Member (third term), Psycho-Oncology Committee, Chinese Anti-Cancer Association; Standing Committee Member (third term), Lung Cancer Committee, Fujian Anti-Cancer Association.
Written by Kateryna Zamkovska
Written by Anna Leonova
Written by Anna Shchur
Written by Kateryna Zamkovska
Written by Kateryna Zamkovska
Chinese cancer centers follow rigorous safety standards including Joint Commission International (JCI) accreditation and the Organisation of European Cancer Institutes (OECI) certifications. Top-tier facilities like Fuda Cancer Hospital and Yanda International Hospital maintain Class A Level III status. This represents the highest medical quality tier in China.
Bookimed Expert Insight: Our data shows a clear link between patient volume and specialized safety. Clinics like Jinshazhou Hospital serve 680,000+ patients annually. High-volume centers often invest more in internationally recognized radiotherapy technologies. They also tend to offer structured multilingual medical travel services to support foreign patients.
Patient Consensus: Patients note that top clinics provide high-tech equipment and specialized nursing care. Some suggest bringing a translator for detailed medical discussions to ensure all treatment steps are clear.
Chinese oncologists demonstrate international expertise through prestigious global memberships, specialized Western training, and clinical research. Leading specialists hold executive roles in organizations like the International Society of Cryosurgery. Many undergo fellowships at top-tier institutions in the United States or participate in global Phase I-IV drug trials.
Bookimed Expert Insight: Patient volume in China drives a unique level of procedural expertise. For example, Dr. Niu Lizhi at Fuda Cancer Hospital has performed nearly 10,000 cryosurgery procedures. This massive clinical exposure, combined with JCI-accredited environments at Yanda International, ensures that theoretical international training is backed by unmatched practical experience.
Patient Consensus: Patients note that top doctors are extremely knowledgeable and the facilities are high-tech. They value the ability to access specialized treatments, like cryoablation, while staying in rooms that feel like high-end hotels.
China achieves high success rates in treating liver, lung, and nasopharyngeal cancers, especially during stages 1 to 3. Specialized centers utilizing cryosurgery and NanoKnife report significant results for advanced cases. Multi-modal protocols combining intensity-modulated radiation therapy (IMRT) and minimally invasive surgery drive these outcomes.
Bookimed Expert Insight: Clinics with massive patient volumes, like Yanda International Hospital serving 2,500,000 patients annually, often provide the most stable outcomes. These high-capacity `Class A level III` facilities combine international protocols with traditional Chinese approaches. This unique integration helps patients manage treatment side effects better than using conventional medicine alone.
Patient Consensus: Patients value how Chinese doctors prioritize organ preservation over radical removal. Many note that high-tech equipment and friendly staff make the hospital environment feel more like a comfortable hotel than a clinical ward.
International oncology patients entering China must provide a complete medical history including pathology reports and biopsy results. These records should include tumor markers and detailed chemotherapy or radiation logs. Most centers require imaging like CT, MRI, or PET scans performed within the last 1–3 months.
Bookimed Expert Insight: Our data shows that high-volume centers like Fuda Cancer Hospital, which serves 30,000+ international patients, often use initial records just for preliminary review. Clinics in Guangzhou or Beijing frequently repeat diagnostics on-site using their specific technology, such as NanoKnife or cryosurgery systems. This ensures the treatment plan matches the hospital's specialized minimally invasive protocols.
Patient Consensus: Patients emphasize that while you should bring every record from home, many Chinese hospitals will still require new scans upon arrival. They suggest having all documents professionally translated to avoid delays during the initial consultation.
Recovery timelines for oncology in China vary by treatment type. Patients undergoing minimally invasive procedures like NanoKnife or cryosurgery often return to light activities within 3 to 7 days. Surgical cases usually require 2 to 4 weeks for basic mobility. International travel is typically safe 10 to 14 days post-surgery.
Bookimed Expert Insight: Data from high-volume centers like Yanda International Hospital and Fuda Cancer Hospital shows a preference for combining international protocols with traditional approaches. This hybrid model often focuses on rapid stabilization. Patients choosing minimally invasive therapies like NanoKnife frequently report shorter hospital stays. This allows for earlier discharge to local hotels compared to traditional open surgeries.
Patient Consensus: Patients note that arriving with a 2-week buffer for monitoring is practical. They emphasize that while some feel ready to fly in 48 hours after non-surgical therapy, staying for a week helps manage unexpected fever or fatigue.
JCI-accredited oncology centers in China provide structured language support through dedicated international departments and multilingual coordinators. Facilities like Fuda Cancer Hospital serve patients from over 100 countries. They offer professional translation services and integrated care pathways for non-Chinese speakers. These services bridge communication gaps during complex cancer treatments.
Bookimed Expert Insight: Data shows that high-volume centers like Yanda International Hospital, serving 2,500,000 patients annually, often specialize in specific regions. For example, Yanda primarily supports Russian and Arabic speakers. Choosing a clinic that already treats high volumes from your specific region ensures more reliable translation and familiar cultural amenities.
Patient Consensus: Patients note that while top-tier private wards feel like 5-star hotels with helpful staff, communication in public wards is difficult without a personal interpreter. Having a dedicated coordinator is essential to understand medical advice and navigate the environment during an oncology stay.
Patients should secure comprehensive medical records in English including pathology slides and imaging before leaving China. It is vital to coordinate with a home oncologist months in advance. You must verify if prescribed medications are approved or available in your home country to ensure treatment continuity.
Bookimed Expert Insight: Data from high-volume centers like Yanda International Hospital, serving 2,500,000 patients annually, shows that successful transitions depend on bridging traditional and international protocols. Patients often overlook that Chinese clinicians, like Dr. Zhang Yanjun at Jinshazhou Hospital, frequently collaborate with U.S. institutions. Asking your Chinese doctor for a direct peer-to-peer contact for your home physician can bypass 90% of local pharmacy delays.
Patient Consensus: Patients emphasize that home doctors often refuse to manage foreign prescriptions without full pathology reports. They suggest bringing a bilingual summary because local pharmacists often struggle with Chinese medication naming conventions and unusual dosing schedules.